Thomas J. Garrity, Director at ANTARES PHARMA, INC. (ATRS), sold 31,000 shares at $4.02 ($125K) on 2012-08-20, disclosed to the SEC on 2012-08-22.
Open-market sale of $125k ATRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ATRS | SELL | 2021-01-13 | $284K | — | Filing → |
| ATRS | SELL | 2019-12-11 | $183K | — | Filing → |
| ATRS | SELL | 2019-05-03 | $80K | — | Filing → |